WHO Academy, Lyon, France | 9-12 November 2026
A 44th invitation to manufacturers of Active Pharmaceutical Ingredients (API) to submit an Expression of Interest (EOI) for API evaluation to the WHO Prequalification of Medicines Programme has bee
WHO has published its first lists of UNFPA-prequalified male latex condoms and TCu380A IUDs acknowledged by WHO, marking an important milestone in the transition of prequalificatio
The Invitation Manufacturers of Reproductive Health Products to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit was recently updated following a reque
The In Vitro Diagnostics Assessment Sessions for 2027 are scheduled as follows:
The Invitation Manufacturers of Medicinal Products for Treatment of Neglected Tropical Disease to Submit an Expression of Interest (EOI) for Product Evaluation to the W
Dolutegravir (sodium) manufactured by Micro Labs Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO has added the BioFire® Global Fever Special Pathogens Panel to the Emergency Use Listing (EUL), expanding access to a quality-assured multiplex diagnost
Bedaquiline fumarate manufactured by Shanghai Neo-Leading Pharma Tech Co., Ltd.
Abacavir (sulfate) (WHOAPI-516) manufactured by Viyash Scientific Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
WHO Prequalification Unit (PQT) added the below new product to its prequalified l
The WHO Prequalification Unit (PQT) has launched eCTD submission capability through the ePQS Portal.
The WHO Prequalification Assessment of Medical Devices (PQT/AMD) is seeking Request for Quotations (RFQs) from interested Notified Bodies to assist in technical documentation review activities for
WHO Prequalification Unit (PQT) added the below new products to its prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified l
WHO Prequalification Team - Medicines (PQT/MED) has issued an updated version of its guidance on the recommended style to be used for visual description of oral dosage forms in WHOPARs.
Lamivudine manufactured by Jiangxi Desano Pharmaceutical Co. Ltd. has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Bedaquiline (fumarate) manufactured by Arene Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Effective 1 September 2026, WHO is expanding the scope of its prequalification programme for in vitro diagnostics (IVDs) to include:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification is expanding its scope to include Interferon-Gamma Release Assays (IGRAs) and targeted Next-Generation Sequencing (tNGS) assays for tuberculosis diagnos
Pyrazinamide manufactured by Resonance Specialities Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
A 43rd invitation to manufacturers of Active Pharmaceutical Ingredients (API) to submit an Expression of Interest (EOI) for API evaluation to the WHO Prequalification of Medicine
The first Invitation to Manufacturers of Medicinal Products for the Treatment of Childhood Cancer to submit applications for evaluation under the WHO Prequalification Programme has been issued foll
The RealStar Filovirus Screen RT-PCR Kit 1.0, manufactured by Diagnostics GmbH, and the RADIONE Ebola/Marburg Detection Kit, manufactured by KH Medical Co., Ltd., have now received WHO Emergency Us
Ritonavir manufactured by Qidong Dongyue Pharmaceutical Co., Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
The following APIs were added:
Between 20 June and 21 July 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequ
The 1st Invitation for the submission of medicinal products for the treatment of Sickle Cell Disease for product evaluation by prequalification has been issued, based on a reques
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Dolutegravir (sodium) manufactured by M/s.
Between 27 May and 19 June 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequa
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
